BioStock: Iconovo initiates collaboration with Affilogic

Iconovo has recently entered into several collaboration agreements, the latest of which with the French biotech company Affilogic. The collaboration concerns a feasibility study with inhalable affinity proteins, so-called Nanofitins, based on Iconovo’s disposable inhaler ICOone. After the study is completed, there are good opportunities to expand the collaboration, according to the company. The goal of the project is to develop a new treatment for lung diseases.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/06/iconovo-initiates-collaboration-with-affilogic/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se